Cargando…
Development and use of active clinical decision support for preemptive pharmacogenomics
BACKGROUND: Active clinical decision support (CDS) delivered through an electronic health record (EHR) facilitates gene-based drug prescribing and other applications of genomics to patient care. OBJECTIVE: We describe the development, implementation, and evaluation of active CDS for multiple pharmac...
Autores principales: | Bell, Gillian C, Crews, Kristine R, Wilkinson, Mark R, Haidar, Cyrine E, Hicks, J Kevin, Baker, Donald K, Kornegay, Nancy M, Yang, Wenjian, Cross, Shane J, Howard, Scott C, Freimuth, Robert R, Evans, William E, Broeckel, Ulrich, Relling, Mary V, Hoffman, James M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957400/ https://www.ncbi.nlm.nih.gov/pubmed/23978487 http://dx.doi.org/10.1136/amiajnl-2013-001993 |
Ejemplares similares
-
Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies
por: Robinson, Katherine M., et al.
Publicado: (2018) -
PREEMPTIVE PHARMACOGENETIC TESTING: EXPLORING THE KNOWLEDGE AND PERSPECTIVES OF UNITED STATES PAYERS
por: Keeling, Nicholas J., et al.
Publicado: (2017) -
Pharmacogenomics cascade testing (PhaCT): a novel approach for preemptive pharmacogenomics testing to optimize medication therapy
por: Roosan, Don, et al.
Publicado: (2020) -
GDSCTools for mining pharmacogenomic interactions in cancer
por: Cokelaer, Thomas, et al.
Publicado: (2018) -
Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing
por: Van Driest, Sara L., et al.
Publicado: (2013)